Management of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection based on a highly sensitive HB core‐related antigen assay-Reference-Cited by-同舟云学术

Management of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection based on a highly sensitive HB core‐related antigen assay

Published:2022-03-09 Issue:9 Volume:52 Page:745-753
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatology Research

Author:

Hagiwara Shinya¹,Kusumoto Shigeru¹^ORCID,Inoue Takako²,Ogawa Shintaro³,Narita Tomoko¹,Ito Asahi¹,Ri Masaki¹,Komatsu Hirokazu¹,Suzuki Takanori⁴,Matsuura Kentaro⁴,Yagi Shintaro⁵,Kaneko Atsushi⁶,Aoyagi Katsumi⁵⁶,Iida Shinsuke¹,Tanaka Yasuhito³⁷^ORCID

Affiliation:

1. Department of Hematology and Oncology Nagoya City University Graduate School of Medical Sciences Nagoya Japan

2. Department of Clinical Laboratory Medicine Nagoya City University Hospital Nagoya Japan

3. Department of Virology and Liver Unit Nagoya City University Graduate School of Medical Sciences Nagoya Japan

4. Department of Gastroenterology and Metabolism Nagoya City University Graduate School of Medical Sciences Nagoya Japan

5. Department of Research and Development Advanced Life Science Institute, Inc. Hachioji Japan

6. Research and Development Division Fujirebio Inc. Hachioji Japan

7. Department of Gastroenterology and Hepatology Kumamoto University Kumamoto Japan

Funder

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13761

Reference22 articles.

1. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy

2. Acute Hepatitis B in a Patient with Antibodies to Hepatitis B Surface Antigen Who Was Receiving Rituximab

3. Mortality Secondary to Fulminant Hepatic Failure in Patients with Prior Resolution of Hepatitis B Virus Infection in Japan

4. Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host disease

5. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T–lymphocyte response

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy;Clinical and Molecular Hepatology;2023-10-01

2. Improved basic performance of iTACT-HBcrAg assay;Journal of Hepatology;2023-09

3. Hepatitis B Core Antibody Level: A Surrogate Marker for Host Antiviral Immunity in Chronic Hepatitis B Virus Infections;Viruses;2023-05-03

4. New Approaches to Chronic Hepatitis B;New England Journal of Medicine;2023-03-23

5. A longitudinal study to detect hepatitis B surface and core-related antigens in chronic hepatitis B patients with hepatitis B surface antigen seroclearance using highly sensitive assays;Journal of Clinical Virology;2023-03